TNK BIOTECH ApS — Credit Rating and Financial Key Figures

CVR number: 30691911
Asylgade 7 A, 2800 Kgs. Lyngby
kledal@smallpharma.dk
tel: 26367552

Income statement (kDKK)

2019
2020
2021
2022
2023
Fiscal period length1212121212
Net sales
Gross profit-13.21-14.16-11.45-10.22-9.25
EBIT-13.21-14.16-11.45-10.22-9.25
Other financial income0.01
Other financial expenses-4.31-4.35-2.91-2.92-1.95
Pre-tax profit-17.52-18.52-14.36-13.15-11.20
Net earnings-17.52-18.52-14.36-13.15-11.20

Assets (kDKK)

2019
2020
2021
2022
2023
Intangible assets total
Tangible assets total
Participating interests20.0020.00
Investments total20.0020.00
Non-current loans receivable20.0020.0020.00
Long term receivables total20.0020.0020.00
Inventories total
Current other receivables2.962.9812.282.40
Short term receivables total2.962.9812.282.40
Cash and bank deposits5.800.0511.8310.53
Cash and cash equivalents5.800.0511.8310.53
Balance sheet total (assets)28.7623.0332.2834.2330.53

Equity and liabilities (kDKK)

2019
2020
2021
2022
2023
Share capital125.00125.00125.00125.00125.00
Retained earnings-99.16- 116.68- 135.19- 149.56- 162.70
Profit of the financial year-17.52-18.52-14.36-13.15-11.20
Shareholders equity total8.32-10.19-24.56-37.70-48.90
Non-current liabilities total
Current loans from credit institutions0.310.20
Current trade creditors9.1010.8010.8811.5010.63
Current owed to participating10.1321.0032.6858.6868.80
Other non-interest bearing current liabilities0.901.4213.091.76
Current liabilities total20.4333.2256.8471.9479.43
Balance sheet total (liabilities)28.7623.0332.2834.2330.53
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.